Cann Group Ltd

Here is the public summary page for Cann Group Ltd. Please login to see the complete information for Cann Group Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Cann Group Ltd stacks up relative to its peers.


Darwin Score-13
TickerCAN
Latest Price0.02 AUD as of close on 09-Jul-2025
3 Month price range0.01 to 0.02 AUD
Market Capitalisation9.54Mn AUD
CountryAustralia
RegionAsia
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryPharmaceuticals
Sub-IndustryPharmaceuticals
Description
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
See More ...
Company URLhttps://www.canngrouplimited.com
See Darwins Full Analysis for Cann Group Ltd

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Cann Group Ltd. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+6
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.-1
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-18

Alerts

There are 4 live alerts for Cann Group Ltd.


Peer Comparison

There are 6 peers of Cann Group Ltd.
Asset NameIndustry GroupPerf(20d)%Asset Score
Ecofibre Ltd (EOF)Pharmaceuticals0-4
Firebrick Pharma Ltd (FRE)Pharmaceuticals-26.8-17
Mayne Pharma Group Ltd (MYX)Pharmaceuticals-1.5-11
Medical Developments International Ltd (MVP)Pharmaceuticals-2.5+2
Neuren Pharmaceuticals Ltd (NEU)Pharmaceuticals-0.8+30
Starpharma Holdings Ltd (SPL)Pharmaceuticals+3.3-9

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn